J.P. Morgan Private Wealth Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $318K | Hold |
4,397
| – | – | ﹤0.01% | 1449 |
|
|
2023
Q2 | $333K | Hold |
4,397
| – | – | ﹤0.01% | 1203 |
|
|
2023
Q1 | $334K | Sell |
4,397
-200
| -4% | -$15.2K | ﹤0.01% | 1636 |
|
|
2022
Q4 | $361K | Buy |
4,597
+26
| +0.6% | +$2.04K | ﹤0.01% | 1589 |
|
|
2022
Q3 | $326K | Buy |
4,571
+258
| +6% | +$18.4K | ﹤0.01% | 1622 |
|
|
2022
Q2 | $323K | Buy |
4,313
+242
| +6% | +$18.1K | ﹤0.01% | 1611 |
|
|
2022
Q1 | $324K | Buy |
4,071
+1,174
| +41% | +$93.4K | ﹤0.01% | 1718 |
|
|
2021
Q4 | $235K | Hold |
2,897
| – | – | ﹤0.01% | 1849 |
|
|
2021
Q3 | $224K | Sell |
2,897
-180
| -6% | -$13.9K | ﹤0.01% | 1813 |
|
|
2021
Q2 | $248K | Buy |
3,077
+350
| +13% | +$28.2K | ﹤0.01% | 1746 |
|
|
2021
Q1 | $215K | Sell |
2,727
-350
| -11% | -$27.6K | ﹤0.01% | 1658 |
|
|
2020
Q4 | $220K | Buy |
+3,077
| New | +$220K | ﹤0.01% | 1613 |
|
|
2020
Q3 | – | Sell |
-3,960
| Closed | -$256K | – | 1616 |
|
|
2020
Q2 | $256K | Sell |
3,960
-80
| -2% | -$5.17K | ﹤0.01% | 1371 |
|
|
2020
Q1 | $222K | Buy |
4,040
+80
| +2% | +$4.4K | ﹤0.01% | 1256 |
|
|
2019
Q4 | $256K | Buy |
+3,960
| New | +$256K | ﹤0.01% | 1304 |
|
|
2019
Q2 | – | Sell |
-3,279
| Closed | -$214K | – | 1441 |
|
|
2019
Q1 | $214K | Sell |
3,279
-408
| -11% | -$26.6K | ﹤0.01% | 1354 |
|
|
2018
Q4 | $230K | Buy |
3,687
+48
| +1% | +$2.99K | ﹤0.01% | 1282 |
|
|
2018
Q3 | $268K | Buy |
3,639
+300
| +9% | +$22.1K | ﹤0.01% | 1356 |
|
|
2018
Q2 | $224K | Sell |
3,339
-120
| -3% | -$8.05K | ﹤0.01% | 1316 |
|
|
2018
Q1 | $216K | Sell |
3,459
-30
| -0.9% | -$1.87K | ﹤0.01% | 1165 |
|
|
2017
Q4 | $224K | Sell |
3,489
-195
| -5% | -$12.5K | ﹤0.01% | 1149 |
|
|
2017
Q3 | $241K | Hold |
3,684
| – | – | ﹤0.01% | 1094 |
|
|
2017
Q2 | $231K | Buy |
3,684
+19
| +0.5% | +$1.19K | ﹤0.01% | 1105 |
|
|
2017
Q1 | $215K | Sell |
3,665
-2,723
| -43% | -$160K | ﹤0.01% | 1210 |
|
|
2016
Q4 | $358K | Buy |
6,388
+2,880
| +82% | +$161K | ﹤0.01% | 926 |
|
|
2016
Q3 | $216K | Buy |
3,508
+255
| +8% | +$15.7K | ﹤0.01% | 1116 |
|
|
2016
Q2 | $206K | Buy |
+3,253
| New | +$206K | ﹤0.01% | 1141 |
|